Drug Comparison · Atypical Antipsychotics

Seroquel vs Abilify

Quetiapine and aripiprazole are both second-generation antipsychotics with overlapping indications — but sharply different side effect profiles, mechanisms, and clinical personalities.

Seroquel
Quetiapine
Seroquel · Seroquel XR
Sedating Antagonist Generic available
VS
Abilify
Aripiprazole
Abilify · Abilify Maintena
Activating Partial agonist Generic available
Advertisement

At a Glance

Quick Comparison

Category Seroquel (quetiapine) Abilify (aripiprazole)
Drug class Atypical (2nd-gen) antipsychotic Atypical (2nd-gen) antipsychotic
Mechanism D2 / 5-HT2A antagonist; strong H1, α1 blockade Partial D2 & 5-HT1A agonist; 5-HT2A antagonist
Available forms IR + XR tablets Tablets + injectable forms
Sedation High Low
Weight gain Significant Minimal
Metabolic risk High Low
Akathisia risk Low Moderate
MDD adjunct (FDA) Yes (XR) Yes
Generic Available Available

Formulations

Available Strengths

Seroquel · quetiapine
Immediate Release (IR)
25 mg 50 mg 100 mg 200 mg 300 mg 400 mg
Extended Release (XR)
50 mg XR 150 mg XR 200 mg XR 300 mg XR 400 mg XR
Abilify · aripiprazole
Oral Tablets
2 mg 5 mg 10 mg 15 mg 20 mg 30 mg
Injectable Forms
IM injection Long-acting (Maintena)

FDA-Approved Uses

Approved Indications

Seroquel
  • Schizophrenia (adults and adolescents)
  • Bipolar I disorder — acute manic episodes
  • Bipolar disorder — depressive episodes (XR)
  • Bipolar I disorder — maintenance (XR, adjunct)
  • MDD adjunct (Seroquel XR only)

Standard-release quetiapine is NOT approved as MDD monotherapy or adjunct.

Abilify
  • Schizophrenia (adults and adolescents)
  • Bipolar I disorder — acute manic / mixed episodes
  • Bipolar I disorder — maintenance
  • MDD adjunct (with antidepressants)
  • Irritability associated with autism spectrum disorder
  • Tourette's disorder

Pharmacology

How Each Drug Works

Seroquel · quetiapine
Broad-spectrum antagonist

Quetiapine blocks multiple receptor types. Its potent antihistamine (H1) antagonism is responsible for sedation and contributes to appetite and weight gain. Alpha-1 blockade causes orthostatic hypotension. D2 and 5-HT2A antagonism provide antipsychotic activity.

D2 antagonist 5-HT2A antagonist H1 antagonist (strong) α1 antagonist M1 antagonist
Abilify · aripiprazole
Partial agonist — a different strategy

Aripiprazole is a partial D2 agonist — functionally unique among antipsychotics. When dopamine activity is too high (psychosis), it acts as a functional antagonist. When dopamine is too low, it provides partial stimulation. This stabilizing effect explains its activating profile and lower metabolic burden.

D2 partial agonist 5-HT1A partial agonist 5-HT2A antagonist D3 partial agonist
⚖️
The core clinical difference

Seroquel sedates and blunts — its H1 blockade makes it calming but metabolically costly. Abilify's partial agonism is activating and metabolically neutral, but that activation can surface as akathisia. Choosing between them often comes down to which side effect profile fits the patient: fatigue and metabolic risk vs. restlessness and insomnia.

Off-Label Spotlight

Seroquel for Sleep: A Controversial Practice

Low-strength quetiapine IR is widely prescribed off-label for insomnia and anxiety, largely because its H1 antihistamine activity produces reliable sedation. This practice is highly controversial among psychiatrists and pharmacologists: even at very low amounts, quetiapine carries metabolic risks — including effects on blood sugar, lipids, and weight — and can cause discontinuation symptoms. Its use for sleep is common in practice but not FDA-approved, and clinical guidelines generally do not endorse it as a first-line sleep treatment.

Abilify, with its activating profile, is not used for sleep and may worsen insomnia in some patients.

Safety

Shared Black Box Warnings

⚠ FDA Black Box Warning — Both Drugs

Increased mortality in elderly patients with dementia-related psychosis

Antipsychotic drugs, including quetiapine and aripiprazole, are not approved for the treatment of dementia-related psychosis. Elderly patients with dementia-related psychosis treated with these drugs are at an increased risk of death. Both drugs carry this warning.

  • Antipsychotics as a class carry a risk of tardive dyskinesia (involuntary movements) — lower than first-generation antipsychotics, but still present with both drugs.
  • Both drugs also carry a warning regarding suicidality in pediatric and young adult patients when used in the context of MDD — a class-wide antidepressant warning that extends to adjunct antipsychotic use.
Advertisement

FAQ

Common Questions

Which causes more weight gain, Seroquel or Abilify?
Seroquel (quetiapine) is associated with significantly more weight gain than Abilify (aripiprazole). Quetiapine's strong antihistamine (H1) activity drives appetite and sedation, contributing to meaningful metabolic changes including dyslipidemia and elevated blood sugar. Aripiprazole is considered metabolically neutral relative to most antipsychotics — its partial agonist mechanism does not carry the same H1 burden, making it one of the lower-risk options for weight and metabolic effects in its class.
Which is better for sleep — Seroquel or Abilify?
Seroquel is widely used off-label for insomnia at low strengths due to its potent antihistamine (H1) blockade, which produces sedation. However, this is a controversial practice: even at sub-therapeutic amounts for psychiatric conditions, quetiapine carries metabolic risks and withdrawal effects. Abilify has an activating profile and is not used for sleep — it may worsen insomnia in some patients. Neither drug is approved as a sleep aid, and sleep-focused use of Seroquel should be discussed carefully with a prescriber.
Which is better for depression — Seroquel or Abilify?
Both are FDA-approved as adjunctive treatments for major depressive disorder (MDD) when added to an antidepressant, but neither is approved as a standalone antidepressant. Seroquel XR has approval for MDD adjunct therapy; standard-release quetiapine does not carry this specific indication. Abilify was among the first atypical antipsychotics approved for MDD augmentation. The choice typically hinges on side effect profile: patients who are fatigued or oversedated may do better with the more activating Abilify, while patients with significant anxiety may tolerate Seroquel's sedating profile.
Can Abilify be taken with an antidepressant?
Yes. Abilify (aripiprazole) is FDA-approved as an add-on (adjunctive) therapy to antidepressants for adults with major depressive disorder who have had an inadequate response to antidepressant treatment alone. This is one of its primary labeled uses. Your prescriber and pharmacist should review any combination for interactions specific to your antidepressant.
Which has fewer side effects — Seroquel or Abilify?
Neither drug is universally "safer" — they trade different risk profiles. Abilify generally has fewer metabolic side effects (less weight gain, less impact on blood sugar and cholesterol) and less sedation. However, Abilify carries a notable risk of akathisia (a subjectively distressing sense of inner restlessness and compulsion to move) that Seroquel does not. Seroquel's main burden is sedation, weight gain, and metabolic effects. The "fewer side effects" drug depends entirely on which side effects matter most to an individual patient.

Explore More

Related Pages

Drug page Quetiapine (Seroquel) Drug page Aripiprazole (Abilify) Comparison Anxiety Medications Browse All Drug Comparisons
Medical disclaimer: This page is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Drug information may not reflect current labeling. Always consult a qualified healthcare provider or pharmacist regarding any medication. Do not start, stop, or change any medication based on information found here.